Molnupiravir shows itself to be antiviral treatment for COVID-19. This innovative drug targets the replication of the SARS-CoV-2 virus, potentially reducing the severity of symptoms. Clinical trials have demonstrated https://www.milanmedicals.com/molnupiravir-200-mg